Customize
Quick Links
About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 1-609-378-3701

Copyright © 2018
Physicians’ Education Resource ®, LLC.
All rights reserved.
Watch Eytan M. Stein, MD; Laura Cicconi, MD; Francesco Lo Coco, MD; and Harry P. Erba, MD, PhD, discuss the value of acute myeloid leukemia (AML) continuing medical education (CME).

Watch Eytan M. Stein, MD; Laura Cicconi, MD; Francesco Lo Coco, MD; and Harry P. Erba, MD, PhD

Value of Oncology CME

Eytan M. Stein, MD; Laura Cicconi, MD; Francesco Lo Coco, MD; and Harry P. Erba, MD, PhD, elaborate on the crucial role that CME in AML plays in advancing patient care. Dr Stein emphasized that CME is a great way to keep abreast of the many clinical trials in patients with AML. Dr Cicconi said that expert CME programs are important to interpret and apply the data coming out of the ongoing clinical trials in hematology. Dr Lo Coco mentioned that it may not be feasible to travel to all of the major scientific meetings and that CME activities, such as this one, are important for physicians to stay updated. Dr Erba felt that CME programs are valuable because they allow community oncologists who treat patients with many types of cancer to hear the advice and opinions of expert subspecialists who focus on leukemia, in this case.
 







Become a Member

Forgot Password?
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
   1234
567891011
12131415161718
19202122232425
262728293031
Filter By